Evaluación del Paciente con Derrame Pleural

Evaluación del Paciente con Derrame Pleural

Publicado 2008-09-01

Abrir | Descargar
PDF FLIP
Número
Vol. 20 Núm. 3 (2008)
Sección
Otros (página para el paciente, cartas al editor y clubes de revistas)
Cómo citar
Evaluación del Paciente con Derrame Pleural.
rev. colomb. neumol. [Internet]. 2008 Sep. 1 [cited 2024 Dec. 22];20(3):133-46.
DOI
Licencia
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Steven A. Sahn
University of South Carolina in Charleston
    Mostrar biografía de los autores

    Steven A. Sahn,

    Professor of Medicine and Director of the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine at the Medical University of South Carolina in Charleston

    Derrames Pleurales son de presentación muy frecuente y son encontrados en pacientes de todas las especialidades clínicas y quirúrgicas. La incidencia anual de nuevos casos de derrames pleurales se calcula es de aproximadamente 1.5 millones en Estados Unidos. La Toracentesis es un procedimiento diagnostico muy simple que se puede hacer en el Consultorio, en la habitación del paciente, en las unidades de cuidado intensivo o en una sala de procedimientos. El estudio del líquido pleural no necesariamente hará diagnósticos exactos pero será una guía muy importante para la orientación clínica del caso. Una cuidadosa y completa historia clínica, un examen clínico completo y detallado, exámenes de laboratorio clínico, una adecuada interpretación de las imágenes radiológicas, previo a la toracentesis diagnóstica, logran con mucha frecuencia hacer un diagnóstico y una orientación adecuada de la investigación de cada caso individual. En este capítulo no solamente desarrollaré el tema acerca del análisis del liquido pleural sino que también resaltaré la importancia de algunos detalles de la historia clínica, del examen físico, de la radiología que conducirán a un diagnóstico diferencial adecuado previo a la Toracentesis diagnóstica.

    Visitas del artículo 234 | Visitas PDF 1002

    Descargas

    Los datos de descarga todavía no están disponibles.
    1. Light RW. Pleural diseases. 4th ed. Baltimore, MD: Lippincott, Williams and Wilkins, 2001.
    2. Carr DT, Mayne JG. Pleurisy with effusion in rheumatoid arthritis, with reference to the low concentration of glucose in pleural fluid. Am Rev Respir Dis 1962; 85:345-350 .
    3. Epler GR, McLoud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 1982; 247:617-622 .
    4. Good JT Jr, King TE, Antony VB, et al. Lupus pleuritis: clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibody titers. Chest 1983; 84:714-718 .
    5. Stelzner TJ, King TE, Antony VB, et al. The pleuropulmonary manifestations of the postcardiac injury syndrome. Chest 1983; 84:383-387.
    6. Sahn SA, Heffner JE. Approach to the patient with pleurisy. In: Kelley WN, ed. Textbook of internal medicine. 2nd ed. Philadelphia, PA: JB Lippincott Company, 1991; 1887-1890..
    7. Sahn SA. Drug-induced pleural disease. In: Camus P, Rosenow E, eds. Drug- induced iatrogenic lung disease. London, UK: Hodder Arnold. In press.
    8. Hopkins HU. Principles and methods of physical diagnosis. 3rd ed. Philadelphia, PA: WB Saunders, 1965; 202-230.
    9. Berger HW, Mejia E. Tuberculous pleurisy. Chest 1973; 63:88-92.
    10. Alptekin F. An epidemic of pleurisy with effusion in Bitlis, Turkey: a study of 559 cases. US Armed Forces Med J 1958; 9:1-11.
    11. Walker WC, Wright V. Pulmonary lesions in rheumatoid arthritis. Medicine 1968; 47:501-519.
    12. Maher GG, Berger HW. Massive pleural effusions: malignant and non-malignant causes in 46 patients. Am Rev Respir Dis 1972; 105:458-460.
    13. Lieberson M. Diagnostic significance of the mediastinal profile in massive unilateral pleural effusions. Am Rev Respir Dis 1963; 88:176-180.
    14. Heller RM, Janower ML, Weber AL. The radiological manifestations of malignant pleural mesothelioma. Am J Roentengol 1971; 108:53-59.
    15. Lorch DG, Sahn SA. Pleural effusions due to diseases below the diaphragm. Sem Respir Med 1987; 9:75-85 .
    16. Rabin CB, Blackman NS. Bilateral pleural effusions: its significance in association with a heart of normal size. J Mt Sinai Hosp 1957; 24:45-53.
    17. Janower ML, Blennerhassett JB. Lymphangitic spread of metastatic cancer to the lung: a radiologic-pathologic classification. Radiology 1971; 101:267-273.
    18. Taylor JR, Ryu J, Colby TV, et al. Lymphangioleiomyomatosis: clinical course in 32 patients. N Engl J Med 1990; 323:1254-1260.
    19. Fine NL, Smith LR, Sheedy PF. Frequency of pleural effusions in mycoplasma and viral pneumonias. N Engl J Med 1970; 283:790-793.
    20. Soskel NT, Sharma OP. Pleural involvement in sarcoidosis: case presentation and detailed review of the literature. Semin Respir Med 1992; 13:492-514.
    21. Horowitz ML, Schiff M, Samuels J, et al. Pneumocystis carinii pleural effusion: pathogenesis and pleural fluid analysis. Am Rev Respir Dis 1993; 148:232-234.
    22. Maguire R, Fauchi AS, Doppman JL, et al. Unusual radiographic features of Wegener’s granulomatosis. Am J Roentengol 1978; 130:233-238.
    23. Gumbs RV, McCauley DI. Hilar and mediastinal adenopathy in septic pulmonary embolic disease. Radiology 1982; 142:313-315.
    24. Rubin SA. Radiographic spectrum of pleuropulmonary tularemia. Am J Roentengol 1978; 131:277-281.
    25. Sahn SA. The pleura. Am Rev Respir Dis 1988; 138:184-234.
    26. Collins TR, Sahn SA. Thoracentesis: complications, patient experience and diagnostic value. Chest 1987; 91:817-822.
    27. Sahn SA. The diagnostic value of pleural fluid analysis. Semin Respir Crit Care Med 1995; 16:269-278.
    28. Nosanchuk JS, Naylor B. A unique cytologic picture in pleural fluid from patients with rheumatoid arthritis. Am J Clin Pathol 1968; 50:330-33.5
    29. Skedros D, Cass S, Hirsch B, et al. Beta-2 transferrin assay in clinical management of cerebral spinal fluid and perilymphatic fluid leaks. J Otolaryngol 1993; 22:341-344.
    30. Joseph J, Sahn SA. Thoracic endometriosis syndrome: new observations from an analysis of 110 cases. Am J Med 1996; 100:164-170.
    31. Doerr C, Allen M, Nichols FR, et al. Etiology of chylothorax in 203 patients. Mayo Clin Proc 2005; 80:867-870.
    32. Coe JE, Aikawa JK. Cholesterol pleural effusion. Arch Intern Med 1961; 108:763-774.
    33. Lillington GA, Carr DT, Mayne JG. Rheumatoid pleurisy with effusion. Arch Intern Med 1971; 128:764-768.
    34. Strange C, Allen ML, Freedland P, et al. Biliopleural fistula as a complication of percutaneous biliary drainage: experimental evidence for pleural inflammation. Am Rev Respir Dis 1988; 137:959-96l.
    35. Sahn SA. Pleural effusions of extravascular origin (PEEVO). Clin Chest Med 2006; 27:285-308.
    36. Stark DD, Shanes JG, Baron RL, et al. Biochemical features of urinothorax. Arch Intern Med 1982; 42:1503-1511.
    37. Light RW, MacGregor I, Lusinger PC, et al. Pleural effusion: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77:507-513.
    38. Heffner JE, Brown LK, Barbieri C. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Chest 1997; 111:970-979.
    39. Joseph J, Badrinath P, Basran G, et al. Is the pleural fluid transudate or exudate? A revisit of the diagnostic criteria. Thorax 2001; 56:867-870.
    40. Winterbauer RH, Riggins RC, Griesman FA, et al. Pleuropulmonary manifestations of Waldentröms macroglobulinemia. Chest 1974; 66:368-375.
    41. Rodriguez JN, Pereira A, Martinez JC, et al. Pleural effusion and multiple myeloma. Chest 1994; 105:622-624.
    42. Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med 1980; 69:507-511.
    43. Potts DE, Levin DC, Sahn SA. Pleural fluid pH and parapneumonic effusions. Chest 1976; 70:328-331.
    44. Pettersson T, Klockers M, Helmstrom PE. Chemical and immunological features of pleural effusions: comparison between rheumatoid arthritis and other diseases. Thorax 1982; 37:354-361.
    45. Johnson JR, Falk A, Iber C, et al. Paragonomyacis in the United States: a report of 9 cases in Hmong immigrants. Chest 1982; 82:168-171.
    46. Light RW, Erozan YS, Ball WC. Cells in pleural fluid: their value in differential diagnosis. Arch Intern Med 1973; 132:854-860.
    47. Pettersson T, Riska H. Diagnostic value of total and differential leukocyte counts in pleural effusions. Acta Med Scand 1981; 210:129-135.
    48. Antony VB, Repine JE, Sahn SA. Experimental models of inflammation in the plerual space. In: Chretien J, Bignon J, Hirsch A, eds. The pleura in health and disease. New York, NY: Marcel Dekker, 1985; 253-266.
    49. Antony VB, Godbey SW, Kunkel SL, et al. Recruitment of inflammatory cells to the pleural space chemotatic cytokines, IL8, and monocyte chemotatic peptide 1 in human pleural fluid. J Immunol 1993; 151:7216-7223.
    50. Antony VB, Sahn SA, Antony AC, et al. Bacillus calmette-guerin stimulated neutrophils release chemotaxins for monocytes in rabbit pleural spaces and in vitro. J Clin Invest 1985; 76:1514-1521.
    51. Yam LT. Diagnostic significance of lymphocytes in pleural effusions. Ann Intern Med 1967; 66:972-982.
    52. Nakamura Y, Ozaki T, Kamei T, et al. Factors that stimulate proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocytes/macrophage colony stimulating factor, interleuken-5, and interleuken-5. Am Rev Cell Mol Biol 1993; 8:605-611.
    53. Askin FB, McCann BG, Kuhn C. Reactive eosinophilic pleuritis. Arch Pathol Lab Med 1997; 101:187-191.
    54. Spriggs AI, Boddington MM. The cytology of effusions. 2nd ed. New York, NY: Grunn and Stratton, 1968 .
    55. Maltais F, Laberge F, Cormier Y. Blood hyper-eosinophilia in the course of posttraumatic pleural effusion. Chest 1990; 98:348-351.
    56. Mattson SB. Monosymptomatic exudative pleurisy in persons exposed to asbestos dust. Scand J Respir Dis 1997; 56:263-272.
    57. Hillerdal G, Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis 1987; 71:113-121.
    58. Rubins JB, Rubins HB. Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest 1996; 110:1271-1274.
    59. Hurwitz S, Leiman G, Shapiro C. Mesothelial cells in pleural fluid: TB or not TB? S Afr Med J 1980; 57:938-939.
    60. Good JT, Taryle DA, Maulitz RM, et al. The diagnostic value of pleural fluid pH. Chest 1980; 78:55-59.
    61. Sahn SA. Pleural fluid pH in the normal state and in diseases affecting the pleural space. In: Chretien J, Bignon J, Hirsch A, eds. The pleura in health and disease. New York, NY: Marcel Dekker, 1985; 253-266 .
    62. Yamada S. Uberdieserose flussig keit in der plerachohle der gesunden menschen. Z Ges Exp Med 1933; 90:343-348.
    63. Sahn SA, Willcox ML, Good JT Jr, et al. Characteristics of normal rabbit pleural fluid: physiologic and biochemical implications. Lung 1979; 156:63-69.
    64. Rolf LL, Travis DM. Pleural fluid-plasma bicarbonate gradients in oxygen-toxic and normal rats. J Physiol 1973; 224:857-861
    65. Heffner JE, Brown LK, Barbieri C. Pleural fluid chemical analysis in parapneumonic effusions: a meta-analysis. Am J Respir Crit Care Med 1995; 51:1700-1708.
    66. Sahn SA, Good JT Jr. Pleural fluid pH in malignant effusions: diagnostic, prognostic, and therapeutic implications. Ann Intern Med 1988; 108:345-349.
    67. Sahn SA. Pathogenesis and clinical features of diseases associated with a low pleural fluid glucose. In: Chretien J, Bignon J, Hirsch A, eds. The pleural in health and disease. New York, NY: Marcel Dekker, 1985; 267-285.
    68. Light RW, Ball WC Jr. Glucose and amylase in pleural effusions. JAMA 1973; 225:257-260.
    69. Kaye MD. Pleuropulmonary complications of pancreatitis. Thorax 1968; 23:297-306.
    70. Joseph J, Viney S, Beck P, et al. A prospective study of amylase-rich pleural effusion with special reference to amylase isoenzyme analysis. Chest 1992; 102:1455-1459.
    71. Rockey DC, Cello JP. Pancreaticopleural fistula: a report of 7 cases and review of the literature. Medicine 1990; 69:332-334.
    72. Maulitz RM, Good JT Jr, Kaplan RL, et al. The pleuropulmonary consequences of esophageal rupture in an experimental model. Am Rev Respir Dis 1979; 120:363-367.
    73. Abbott OA, Mansour KA, Logan WD Jr, et al. A traumatic so-called «spontaneous» rupture of the esophagus: a review of 47 personal cases with comments on the new method of surgical therapy. J Thorac Cardiov Sur 1970; 59:67-83.
    74. Sherr HP, Light RW, Morson MH, et al. Origin of pleural fluid amylase in esophageal rupture. Ann Intern Med 1972; 76:75-76.
    75. Ende N. Studies of amylase activity in pleural effusions and ascites. Cancer 1960; 13:283-287.
    76. Kramer MR, Sepero RJ, Pitchenik AE. High amylase in neoplasm-related pleural effusions. Ann Intern Med 1989; 110:567-569.
    77. Staats BA, Ellefson RD, Budahn LL, et al. The lipoprotein profile of chylous and non-chylous pleural effusions. Mayo Clin Proc 1980;55:700-704.
    78. Teba L, Dedhia AT, Bowen R, et al. Chylothorax review. Crit Care Med 1985; 13:49-52.
    79. Hamm H, Pfalzer B, Fabell H. Lipoprotein analysis in a chyloform pleural effusion: implications for pathogenesis and diagnosis. Respiration 1991; 58:294-300.
    80. Grunze H. The comparitive diagnostic accuracy, efficiency, and specificity of cytologic techniques used in the diagnosis of malignant neoplasm and serous effusions of the pleuroperitoneal cavities. Acta Cytol 1964; 8:150-164
    81. Jarvi OH, Kunnas RJ, Laitio MT, et al. The accuracy and significance of cytologic cancer diagnosis of pleural effusions. Acta Cytol 1972; 16:152-157.
    82. Sahn SA. Malignant pleural effusions. Semin Respir Med 1987; 9:43-53.
    83. Naylor B, Schmidt RW. The case for exfoliator cytology of serous effusions. Lancet 1964; 1:711-712.
    84. Melamed MR. The cytologic presentation of malignant lymphomas in related diseases and effusions. Cancer 1963; 16:413-431.
    85. Moriarty AT, Wiersema L, Snyder W, et al. Immunophenotyping of cytologic specimens by flow cytometry. Diagn Cytopathol 1993; 9:252.
    Tutoriales

    Autores:

    ¿Cómo enviar un artículo?

    Par evaluador:

    ¿Cómo evaluar un artículo?

    Información

    Historia de la revista

    Palabras clave

    Directorios e indexadores

     

    Patrocinadores

     Nos apoyan + Info Aquí 

    Perfil de Google Scholar

    Más leídos en los últimos 30 días

    Número actual

    Código QR

    Sistema OJS 3.4.0.7 - Metabiblioteca |